LGND: Ligand Pharmaceuticals Incorporated Stock

by  •  • Comments Off on LGND: Ligand Pharmaceuticals Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,039.20
Enterprise Value ($M) 1,830.30
Book Value ($M) 795.53
Book Value / Share 41.23
Price / Book 2.56
NCAV ($M) 199.41
NCAV / Share 10.34
Price / NCAV 10.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.16

Liquidity (mrq)
Quick Ratio 5.02
Current Ratio 5.27

Balance Sheet (mrq) ($M)
Current Assets 309.32
Assets 905.43
Liabilities 109.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 167.13
Operating Income 23.02
Net Income -4.03
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 97.05
Cash from Investing -143.66
Cash from Financing 97.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
22 hours ago 13G/A Janus Henderson Group Plc 5.30 1.28
02-05 13G/A BlackRock, Inc. 15.60 -0.55
11-08 13G/A Goldman Sachs Group Inc 0.30 -95.57
11-01 13G/A Macquarie Group Ltd 4.86 -10.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 32,964 118,864 27.73
2025-05-12 30,598 106,733 28.67
2025-05-09 42,040 131,906 31.87
2025-05-08 53,187 153,824 34.58

(click for more detail)

Similar Companies
KOD – Kodiak Sciences Inc. KROS – Keros Therapeutics, Inc.
KYMR – Kymera Therapeutics, Inc. LNTH – Lantheus Holdings, Inc.
LRMR – Larimar Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io